X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (4103) 4103
Publication (180) 180
Book Review (33) 33
Book / eBook (28) 28
Book Chapter (15) 15
Magazine Article (10) 10
Conference Proceeding (2) 2
Dissertation (2) 2
Data Set (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
female (3986) 3986
humans (3983) 3983
middle aged (1992) 1992
adult (1861) 1861
uterine cervical neoplasms - diagnostic imaging (1756) 1756
index medicus (1702) 1702
uterine cervical neoplasms - pathology (1546) 1546
aged (1341) 1341
cervical cancer (1211) 1211
oncology (1145) 1145
radiology, nuclear medicine & medical imaging (938) 938
cancer (924) 924
uterine cervical neoplasms - radiotherapy (780) 780
carcinoma (749) 749
uterine cervical neoplasms - diagnosis (743) 743
tomography, x-ray computed (695) 695
neoplasm staging (679) 679
obstetrics & gynecology (619) 619
magnetic resonance imaging (600) 600
uterine cervical neoplasms - surgery (567) 567
radiotherapy (525) 525
diagnosis (489) 489
retrospective studies (476) 476
aged, 80 and over (457) 457
sensitivity and specificity (455) 455
lymphatic metastasis (444) 444
prognosis (413) 413
radiography (412) 412
uterine cervix (375) 375
care and treatment (374) 374
uterine cervical neoplasms - therapy (348) 348
hysterectomy (345) 345
ultrasonography (342) 342
carcinoma, squamous cell - diagnostic imaging (340) 340
treatment outcome (325) 325
fluorodeoxyglucose f18 (312) 312
radiotherapy dosage (308) 308
carcinoma, squamous cell - pathology (307) 307
prospective studies (307) 307
male (292) 292
research (288) 288
radiopharmaceuticals (279) 279
surgery (278) 278
uterine neoplasms - diagnostic imaging (277) 277
metastasis (271) 271
tumors (268) 268
follow-up studies (266) 266
chemotherapy (263) 263
women (261) 261
diagnosis, differential (258) 258
lymph nodes - pathology (256) 256
biopsy (254) 254
lymphography (252) 252
pathology (252) 252
positron-emission tomography (252) 252
hematology, oncology and palliative medicine (250) 250
radiation-therapy (249) 249
brachytherapy (246) 246
reproducibility of results (244) 244
lymph nodes - diagnostic imaging (243) 243
cervix (238) 238
magnetic resonance imaging - methods (233) 233
brachytherapy - methods (231) 231
patients (227) 227
young adult (223) 223
radiology (221) 221
health aspects (219) 219
cervix uteri - pathology (217) 217
lymphatic metastasis - diagnostic imaging (215) 215
radionuclide imaging (208) 208
mri (202) 202
positron-emission-tomography (202) 202
predictive value of tests (195) 195
adenocarcinoma - diagnostic imaging (194) 194
uterine cervical neoplasms - drug therapy (192) 192
endometrial cancer (188) 188
medicine (188) 188
adenocarcinoma - pathology (187) 187
medicine & public health (186) 186
lymph node excision (182) 182
methods (180) 180
radical hysterectomy (180) 180
uterine cervical neoplasms - metabolism (180) 180
computed-tomography (177) 177
risk factors (177) 177
neoplasm invasiveness (175) 175
ultrasound (172) 172
uterine cervical neoplasms - mortality (170) 170
uterine neoplasms - pathology (170) 170
therapy (163) 163
uterus (163) 163
pregnancy (162) 162
cervix uteri - diagnostic imaging (160) 160
radiation therapy (160) 160
usage (160) 160
endometrial neoplasms - pathology (159) 159
adolescent (158) 158
squamous-cell carcinoma (158) 158
time factors (156) 156
neoplasms (152) 152
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3495) 3495
German (208) 208
French (116) 116
Russian (83) 83
Japanese (78) 78
Italian (41) 41
Spanish (29) 29
Chinese (23) 23
Polish (22) 22
Czech (14) 14
Bulgarian (12) 12
Serbian (7) 7
Norwegian (5) 5
Portuguese (5) 5
Slovak (5) 5
Ukrainian (5) 5
Danish (4) 4
Hungarian (4) 4
Dutch (3) 3
Lithuanian (2) 2
Swedish (2) 2
Finnish (1) 1
Hebrew (1) 1
Korean (1) 1
Romanian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Gynecologic Oncology, ISSN 0090-8258, 2013, Volume 130, Issue 1, pp. 75 - 80
Abstract Objective Cervical and vaginal cancers have virally-mediated or mutated defects in DNA damage repair responses, making these cancers sensible targets... 
Hematology, Oncology and Palliative Medicine | Obstetrics and Gynecology | Ribonucleotide reductase | Radiosensitization | Cervical cancer | Triapine | CONCURRENT CISPLATIN | GYNECOLOGIC-ONCOLOGY-GROUP | DNA-DAMAGE | CHEMOTHERAPY | RADIATION-THERAPY | OBSTETRICS & GYNECOLOGY | F-18-FDG PET | ONCOLOGY | PELVIC IRRADIATION | PHASE-I | IVA CARCINOMA | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Tomography, X-Ray Computed | Uterine Cervical Neoplasms - pathology | Positron-Emission Tomography | Thiosemicarbazones - administration & dosage | Vaginal Neoplasms - drug therapy | Chemoradiotherapy | Cisplatin - administration & dosage | Pyridines - adverse effects | Multimodal Imaging - methods | Adult | Female | Brachytherapy | Vaginal Neoplasms - radiotherapy | Pyridines - administration & dosage | Uterine Cervical Neoplasms - radiotherapy | Drug Administration Schedule | Vaginal Neoplasms - pathology | Uterine Cervical Neoplasms - drug therapy | Vaginal Neoplasms - diagnostic imaging | Thiosemicarbazones - adverse effects | Cisplatin - adverse effects | Fluorodeoxyglucose F18 | Uterine Cervical Neoplasms - diagnostic imaging | Aged | Neoplasm Staging | Index Medicus | ribonucleotide reductase | cervical cancer | radiosensitization
Journal Article
PLoS ONE, ISSN 1932-6203, 05/2016, Volume 11, Issue 5, p. e0155333
Objectives To investigate fused multiparametric positron emission tomography/magnetic resonance imaging (MP PET/MRI) at 3T in patients with locally advanced... 
FDG-PET | UTERINE CERVIX | GYNECOLOGIC MALIGNANCIES | PREDICTIVE ASSAY | MRI | MULTIDISCIPLINARY SCIENCES | PIMONIDAZOLE | RADIOTHERAPY | HYPOXIA | CARCINOMA | RADIATION-THERAPY | Fluorodeoxyglucose F18 - pharmacokinetics | Carcinoma, Squamous Cell - pathology | Humans | Middle Aged | Image Interpretation, Computer-Assisted | Magnetic Resonance Imaging - methods | Uterine Cervical Neoplasms - pathology | Carcinoma, Squamous Cell - diagnostic imaging | Misonidazole - pharmacokinetics | Misonidazole - analogs & derivatives | Positron-Emission Tomography - methods | Tumor Burden | Disease Progression | Multimodal Imaging - methods | Adult | Female | Uterine Cervical Neoplasms - diagnostic imaging | Aged | Retrospective Studies | Neoplasm Staging | Usage | Care and treatment | Magnetic resonance imaging | PET imaging | Research | Diagnosis | Cervical cancer | Nuclear medicine | Nuclear magnetic resonance--NMR | Laboratories | Emission analysis | Radiation | Oncology | Gender | Cancer therapies | Angiogenesis | Heterogeneity | Tomography | Statistical analysis | Medical imaging | Data acquisition | Invasiveness | Gynecology | Feasibility studies | Positron emission | Radiation therapy | Metabolism | Patients | Obstetrics | Diffusivity | Emissions | Correlation analysis | Hypoxia | Avidity | Resonance | Kinetics | Median (statistics) | Positron emission tomography | Tumors | Cancer | Nuclear magnetic resonance | NMR
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2010, Volume 76, Issue 1, pp. 104 - 109
Purpose To determine current practice patterns with regard to three-dimensional (3D) imaging for gynecologic brachytherapy among American Brachytherapy Society... 
Radiology | Hematology, Oncology and Palliative Medicine | 3D image based brachytherapy | Survey | Cervical cancer | DOSE-VOLUME PARAMETERS | CERVICAL-CANCER BRACHYTHERAPY | RECTUM | INTRACAVITARY BRACHYTHERAPY | COMPUTED-TOMOGRAPHY | UTERINE CERVIX | WORKING GROUP | ONCOLOGY | OPTIMIZATION | BLADDER | CARCINOMA | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Radiotherapy Dosage | Practice Patterns, Physicians' - standards | Uterine Cervical Neoplasms - radiotherapy | United States | Humans | Ultrasonography, Interventional - utilization | Brachytherapy - methods | Imaging, Three-Dimensional - methods | Tomography, X-Ray Computed - methods | Uterine Cervical Neoplasms - pathology | Tumor Burden | Magnetic Resonance Imaging | Practice Patterns, Physicians' - statistics & numerical data | Imaging, Three-Dimensional - utilization | Societies, Medical | Rectum - diagnostic imaging | Urinary Bladder - diagnostic imaging | Female | Uterine Cervical Neoplasms - diagnostic imaging | Tomography, X-Ray Computed - utilization | Radiation Oncology - statistics & numerical data | Health Care Surveys | Radiation Oncology - standards | Surveys | Oil field services | TOMOGRAPHY | DIAGNOSTIC TECHNIQUES | NEOPLASMS | UROGENITAL SYSTEM DISEASES | THREE-DIMENSIONAL CALCULATIONS | MEDICINE | COMPUTERIZED TOMOGRAPHY | NUCLEAR MEDICINE | CAT SCANNING | PLANNING | DISEASES | THERAPY | RADIOLOGY AND NUCLEAR MEDICINE | RADIOTHERAPY | BRACHYTHERAPY | RADIOLOGY
Journal Article
Gynecologic Oncology, ISSN 0090-8258, 06/2019, Volume 153, Issue 3, pp. 530 - 534
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2014, Volume 90, Issue 5, pp. 1099 - 1107
Purpose To quantify the relationship between bone marrow (BM) response to radiation and radiation dose by using18 F-labeled fluorodeoxyglucose positron... 
Radiology | Hematology, Oncology and Palliative Medicine | SURVIVAL | CONSENSUS GUIDELINES | DELINEATION | CLINICAL TARGET VOLUME | CISPLATIN | ONCOLOGY | CONCURRENT CHEMOTHERAPY | INTENSITY-MODULATED RADIOTHERAPY | PELVIC RADIOTHERAPY | EMISSION-TOMOGRAPHY | PARAMETERS | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | Fluorodeoxyglucose F18 - pharmacokinetics | Chemoradiotherapy - adverse effects | Humans | Middle Aged | Tomography, X-Ray Computed - methods | Bone Marrow - radiation effects | Carcinoma, Squamous Cell - diagnostic imaging | Bone Marrow Cells - diagnostic imaging | Cisplatin - administration & dosage | Multimodal Imaging | Radiation-Sensitizing Agents - administration & dosage | Bone Marrow - metabolism | Aged, 80 and over | Adult | Female | Bone Marrow - diagnostic imaging | Retrospective Studies | Uterine Cervical Neoplasms - therapy | Radiotherapy Dosage | Acute Disease | Chemoradiotherapy - methods | Radiopharmaceuticals - pharmacokinetics | Radiotherapy, Intensity-Modulated - methods | Carcinoma, Squamous Cell - therapy | Bone Marrow Cells - radiation effects | Positron-Emission Tomography - methods | Blood Cell Count | Regression Analysis | Adenocarcinoma - therapy | Uterine Cervical Neoplasms - diagnostic imaging | Aged | Adenocarcinoma - diagnostic imaging | Bone Marrow Cells - metabolism | Cancer patients | Care and treatment | PET imaging | Radiation | Sport-utility vehicles | Standards | Cervical cancer | Cancer | DIAGNOSIS | PATIENTS | NEOPLASMS | FLUORODEOXYGLUCOSE | BONE MARROW | RADIATION DOSES | TOXICITY | SKELETON | POSITRON COMPUTED TOMOGRAPHY | UPTAKE | RADIOLOGY AND NUCLEAR MEDICINE | BLOOD CELLS | RADIOTHERAPY | FLUORINE 18
Journal Article
Journal Article
Journal Article
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2014, Volume 90, Issue 5, pp. 1091 - 1098
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2010, Volume 77, Issue 4, pp. 1085 - 1091
Purpose This study aimed to evaluate the toxicity and clinical outcomes for cervical cancer patients treated definitively with intensity-modulated radiation... 
Radiology | Hematology, Oncology and Palliative Medicine | FDG-PET/CT | IMRT | Cervix | Image guidance | Non-IMRT | PELVIC RADIOTHERAPY | LUNG-CANCER | CT | CISPLATIN | ONCOLOGY | CONCURRENT CHEMOTHERAPY | HIGH-RISK | OBSERVER VARIATION | CARCINOMA | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | PET | TUMOR VOLUME | Multivariate Analysis | Prospective Studies | Uterine Cervical Neoplasms - radiotherapy | Humans | Middle Aged | Radiotherapy, Intensity-Modulated - methods | Tomography, X-Ray Computed - methods | Uterine Cervical Neoplasms - drug therapy | Uterine Cervical Neoplasms - pathology | Positron-Emission Tomography - methods | Radiotherapy, Intensity-Modulated - adverse effects | Disease-Free Survival | Neoplasm Recurrence, Local - diagnostic imaging | Female | Fluorodeoxyglucose F18 | Uterine Cervical Neoplasms - diagnostic imaging | Combined Modality Therapy - methods | Radiopharmaceuticals | Brachytherapy - adverse effects | Index Medicus | TOMOGRAPHY | HOURS LIVING RADIOISOTOPES | EMISSION COMPUTED TOMOGRAPHY | FLUORODEOXYGLUCOSE | UROGENITAL SYSTEM DISEASES | MEDICINE | CAT SCANNING | ANTIMETABOLITES | FLUORINE ISOTOPES | THERAPY | NANOSECONDS LIVING RADIOISOTOPES | POSITRON COMPUTED TOMOGRAPHY | DRUGS | BETA DECAY RADIOISOTOPES | RADIOLOGY AND NUCLEAR MEDICINE | RADIOTHERAPY | LIGHT NUCLEI | RADIOLOGY | BETA-PLUS DECAY RADIOISOTOPES | DIAGNOSTIC TECHNIQUES | NEOPLASMS | ISOMERIC TRANSITION ISOTOPES | RADIOISOTOPES | COMPUTERIZED TOMOGRAPHY | NUCLEAR MEDICINE | ISOTOPES | DISEASES | NUCLEI | ODD-ODD NUCLEI | BRACHYTHERAPY | FLUORINE 18
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 2016, Volume 97, Issue 3, pp. 546 - 553
Purpose To determine whether apparent diffusion coefficient (ADC) value is predictive of survival after definitive chemoradiation for cervical cancer... 
Radiology | Hematology, Oncology and Palliative Medicine | 18F-FDG PET/CT | ONCOLOGY-GROUP | COEFFICIENT | PRETREATMENT | ONCOLOGY | FREE SURVIVAL | CONCURRENT CHEMOTHERAPY | DISEASE RECURRENCE | PROGNOSTIC-SIGNIFICANCE | STAGE IB | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | RADIATION-THERAPY | Adenocarcinoma - pathology | Prognosis | Carcinoma, Squamous Cell - pathology | Humans | Middle Aged | Uterine Cervical Neoplasms - pathology | Antineoplastic Agents - therapeutic use | Carcinoma, Squamous Cell - diagnostic imaging | Chemoradiotherapy | Radiation-Sensitizing Agents - therapeutic use | Carcinoma, Squamous Cell - mortality | Neoplasm Recurrence, Local - diagnostic imaging | Aged, 80 and over | Adult | Female | Brachytherapy | Uterine Cervical Neoplasms - mortality | Uterine Cervical Neoplasms - therapy | Carcinoma, Squamous Cell - therapy | Positron Emission Tomography Computed Tomography | Disease-Free Survival | Adenocarcinoma - therapy | Analysis of Variance | Cisplatin - therapeutic use | Uterine Cervical Neoplasms - diagnostic imaging | Aged | Adenocarcinoma - diagnostic imaging | Diffusion Magnetic Resonance Imaging - methods | Adenocarcinoma - mortality | Radiotherapy, Intensity-Modulated | Care and treatment | Magnetic resonance imaging | Patient outcomes | Cervical cancer | Radiation | Cancer | Radiotherapy | Scanning devices
Journal Article